{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T03:34:56Z","timestamp":1792640096033,"version":"4.5.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2012,8,30]],"date-time":"2012-08-30T00:00:00Z","timestamp":1346284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2012,8,30]],"date-time":"2012-08-30T00:00:00Z","timestamp":1346284800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Protoc"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1038\/nprot.2012.097","type":"journal-article","created":{"date-parts":[[2012,8,30]],"date-time":"2012-08-30T15:53:19Z","timestamp":1346341999000},"page":"1755-1764","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":163,"title":["Primary culture and immortalization of human fallopian tube secretory epithelial cells"],"prefix":"10.1038","volume":"7","author":[{"given":"Alison M","family":"Karst","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronny","family":"Drapkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,8,30]]},"reference":[{"key":"BFnprot2012097_CR1","doi-asserted-by":"publisher","first-page":"7547","DOI":"10.1073\/pnas.1017300108","volume":"108","author":"AM Karst","year":"2011","unstructured":"Karst, A.M., Levanon, K. & Drapkin, R. Modeling high-grade serous ovarian carcinogenesis from the fallopian tube. Proc. Natl. Acad. Sci. USA 108, 7547\u20137552 (2011).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnprot2012097_CR2","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1097\/01.pas.0000180854.28831.77","volume":"30","author":"F Medeiros","year":"2006","unstructured":"Medeiros, F. et al. The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome. Am. J. Surg. Pathol. 30, 230\u2013236 (2006).","journal-title":"Am. J. Surg. Pathol."},{"key":"BFnprot2012097_CR3","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1002\/path.2091","volume":"211","author":"Y Lee","year":"2007","unstructured":"Lee, Y. et al. A candidate precursor to serous carcinoma that originates in the distal fallopian tube. J. Pathol. 211, 26\u201335 (2007).","journal-title":"J. Pathol."},{"key":"BFnprot2012097_CR4","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.molonc.2009.01.004","volume":"3","author":"CP Crum","year":"2009","unstructured":"Crum, C.P. Intercepting pelvic cancer in the distal fallopian tube: theories and realities. Mol. Oncol. 3, 165\u2013170 (2009).","journal-title":"Mol. Oncol."},{"key":"BFnprot2012097_CR5","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1097\/PAS.0b013e3181ef7b16","volume":"34","author":"CG Przybycin","year":"2010","unstructured":"Przybycin, C.G., Kurman, R.J., Ronnett, B.M., Shih Ie, M. & Vang, R. Are all pelvic (nonuterine) serous carcinomas of tubal origin? Am. J. Surg. Pathol. 34, 1407\u20131416 (2010).","journal-title":"Am. J. Surg. Pathol."},{"key":"BFnprot2012097_CR6","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/GCO.0b013e328011a21f","volume":"19","author":"CP Crum","year":"2007","unstructured":"Crum, C.P. et al. The distal fallopian tube: a new model for pelvic serous carcinogenesis. Curr. Opin. Obstet. Gynecol. 19, 3\u20139 (2007).","journal-title":"Curr. Opin. Obstet. Gynecol."},{"key":"BFnprot2012097_CR7","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/j.humpath.2011.03.003","volume":"42","author":"RJ Kurman","year":"2011","unstructured":"Kurman, R.J. & Shih Ie, M. Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer\u2014shifting the paradigm. Hum. Pathol. 42, 918\u2013931 (2011).","journal-title":"Hum. Pathol."},{"key":"BFnprot2012097_CR8","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1111\/IGC.0b013e318199009c","volume":"19","author":"S Salvador","year":"2009","unstructured":"Salvador, S. et al. The fallopian tube: primary site of most pelvic high-grade serous carcinomas. Int. J. Gynecol. Cancer 19, 58\u201364 (2009).","journal-title":"Int. J. Gynecol. Cancer"},{"key":"BFnprot2012097_CR9","doi-asserted-by":"publisher","first-page":"932371","DOI":"10.1155\/2010\/932371","volume":"2010","author":"AM Karst","year":"2010","unstructured":"Karst, A.M. & Drapkin, R. Ovarian cancer pathogenesis: a model in evolution. J. Oncol. 2010, 932371 (2010).","journal-title":"J. Oncol."},{"key":"BFnprot2012097_CR10","doi-asserted-by":"publisher","first-page":"5284","DOI":"10.1200\/JCO.2008.18.1107","volume":"26","author":"K Levanon","year":"2008","unstructured":"Levanon, K., Crum, C. & Drapkin, R. New insights into the pathogenesis of serous ovarian cancer and its clinical impact. J. Clin. Oncol. 26, 5284\u20135293 (2008).","journal-title":"J. Clin. Oncol."},{"key":"BFnprot2012097_CR11","doi-asserted-by":"publisher","first-page":"19.e1","DOI":"10.1016\/j.ajog.2010.05.038","volume":"204","author":"MH Greene","year":"2011","unstructured":"Greene, M.H., Mai, P.L. & Schwartz, P.E. Does bilateral salpingectomy with ovarian retention warrant consideration as a temporary bridge to risk-reducing bilateral oophorectomy in BRCA1\/2 mutation carriers? Am. J. Obstet. Gynecol. 204, 19.e1\u201319.e6 (2011).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"BFnprot2012097_CR12","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.ygyno.2009.01.013","volume":"113","author":"AK Folkins","year":"2009","unstructured":"Folkins, A.K., Jarboe, E.A., Roh, M.H. & Crum, C.P. Precursors to pelvic serous carcinoma and their clinical implications. Gynecol. Oncol. 113, 391\u2013396 (2009).","journal-title":"Gynecol. Oncol."},{"key":"BFnprot2012097_CR13","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1038\/onc.2009.402","volume":"29","author":"K Levanon","year":"2010","unstructured":"Levanon, K. et al. Primary ex vivo cultures of human fallopian tube epithelium as a model for serous ovarian carcinogenesis. Oncogene 29, 1103\u20131113 (2010).","journal-title":"Oncogene"},{"key":"BFnprot2012097_CR14","doi-asserted-by":"crossref","unstructured":"Fotheringham, S., Levanon, K. & Drapkin, R. Ex vivo culture of primary human fallopian tube epithelial cells. J. Vis. Exp. doi:10.3791\/2728 (2011).","DOI":"10.3791\/2728"},{"key":"BFnprot2012097_CR15","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3410\/M3-22","volume":"3","author":"AM Karst","year":"2011","unstructured":"Karst, A.M. & Drapkin, R. The new face of ovarian cancer modeling: better prospects for detection and treatment. F1000 Med. Rep. 3, 22 (2011).","journal-title":"F1000 Med. Rep."},{"key":"BFnprot2012097_CR16","doi-asserted-by":"crossref","unstructured":"Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature 474, 609\u2013615 (2011).","DOI":"10.1038\/nature10166"},{"key":"BFnprot2012097_CR17","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/sj.bjc.6604820","volume":"100","author":"CL Pearce","year":"2009","unstructured":"Pearce, C.L. et al. Validating genetic risk associations for ovarian cancer through the International Ovarian Cancer Association Consortium. Br. J. Cancer 100, 412\u2013420 (2009).","journal-title":"Br. J. Cancer"},{"key":"BFnprot2012097_CR18","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.molonc.2009.01.008","volume":"3","author":"PA Fasching","year":"2009","unstructured":"Fasching, P.A. et al. Role of genetic polymorphisms and ovarian cancer susceptibility. Mol. Oncol. 3, 171\u2013181 (2009).","journal-title":"Mol. Oncol."},{"key":"BFnprot2012097_CR19","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1038\/ng.668","volume":"42","author":"EL Goode","year":"2010","unstructured":"Goode, E.L. et al. A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24. Nat. Genet. 42, 874\u2013879 (2010).","journal-title":"Nat. Genet."},{"key":"BFnprot2012097_CR20","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1158\/1078-0432.CCR-08-1564","volume":"15","author":"D Etemadmoghadam","year":"2009","unstructured":"Etemadmoghadam, D. et al. Integrated genome-wide DNA copy number and expression analysis identifies distinct mechanisms of primary chemoresistance in ovarian carcinomas. Clin. Cancer Res. 15, 1417\u20131427 (2009).","journal-title":"Clin. Cancer Res."},{"key":"BFnprot2012097_CR21","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1002\/ijc.25554","volume":"128","author":"M Notaridou","year":"2011","unstructured":"Notaridou, M. et al. Common alleles in candidate susceptibility genes associated with risk and development of epithelial ovarian cancer. Int. J. Cancer 128, 2063\u20132074 (2011).","journal-title":"Int. J. Cancer"},{"key":"BFnprot2012097_CR22","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1038\/ng.666","volume":"42","author":"KL Bolton","year":"2010","unstructured":"Bolton, K.L. et al. Common variants at 19p13 are associated with susceptibility to ovarian cancer. Nat. Genet. 42, 880\u2013884 (2010).","journal-title":"Nat. Genet."},{"key":"BFnprot2012097_CR23","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1593\/neo.11138","volume":"13","author":"AA Jazaeri","year":"2011","unstructured":"Jazaeri, A.A. et al. Molecular requirements for transformation of fallopian tube epithelial cells into serous carcinoma. Neoplasia 13, 899\u2013911 (2011).","journal-title":"Neoplasia"},{"key":"BFnprot2012097_CR24","first-page":"4239","volume":"10","author":"DG Miller","year":"1990","unstructured":"Miller, D.G., Adam, M.A. & Miller, A.D. Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection. Mol. Cell Biol. 10, 4239\u20134242 (1990).","journal-title":"Mol. Cell Biol."},{"key":"BFnprot2012097_CR25","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.bcmd.2004.04.001","volume":"33","author":"E Kanbe","year":"2004","unstructured":"Kanbe, E. & Zhang, D.E. A simple and quick method to concentrate MSCV retrovirus. Blood Cells Mol. Dis. 33, 64\u201367 (2004).","journal-title":"Blood Cells Mol. Dis."},{"key":"BFnprot2012097_CR26","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1097\/PAS.0b013e3181da7687","volume":"34","author":"AR Laury","year":"2010","unstructured":"Laury, A.R. et al. PAX8 reliably distinguishes ovarian serous tumors from malignant mesothelioma. Am. J. Surg. Pathol. 34, 627\u2013635 (2010).","journal-title":"Am. J. Surg. Pathol."},{"key":"BFnprot2012097_CR27","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.ygyno.2006.08.052","volume":"104","author":"NJ Bowen","year":"2007","unstructured":"Bowen, N.J. et al. Emerging roles for PAX8 in ovarian cancer and endosalpingeal development. Gynecol. Oncol. 104, 331\u2013337 (2007).","journal-title":"Gynecol. Oncol."},{"key":"BFnprot2012097_CR28","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1038\/nprot.2006.239","volume":"1","author":"BS Herbert","year":"2006","unstructured":"Herbert, B.S., Hochreiter, A.E., Wright, W.E. & Shay, J.W. Nonradioactive detection of telomerase activity using the telomeric repeat amplification protocol. Nat. Protoc. 1, 1583\u20131590 (2006).","journal-title":"Nat. Protoc."}],"container-title":["Nature Protocols"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/nprot.2012.097.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nprot.2012.097","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nprot.2012.097.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,27]],"date-time":"2021-12-27T20:04:00Z","timestamp":1640635440000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nprot.2012.097"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,30]]},"references-count":28,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["BFnprot2012097"],"URL":"https:\/\/doi.org\/10.1038\/nprot.2012.097","relation":{},"ISSN":["1754-2189","1750-2799"],"issn-type":[{"value":"1754-2189","type":"print"},{"value":"1750-2799","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8,30]]},"assertion":[{"value":"30 August 2012","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}